Combining tomosynthesis plus digital mammography screening’s effect on cancer detection and recall rates.
Adding tomosynthesis to digital screening mammography increases cancer detection rates while decreasing recall rates, according to a study published in Breast Cancer Research and Treatment.
Researchers from several states in the U.S. sought to determine the effect of tomosynthesis imaging as a function of age for breast cancer screening. To do this, the researchers examined and compared screening performance metrics from 13 institutions for 12 months prior to introduction of tomosynthesis with those performed after introduction of tomosynthesis. The time ranged from three to 22 months. The women were grouped into ages 40 to 49, 50 to 59, 60 to 69, and 70 and older. The data included rates per 1,000 screens for recalls, biopsies, cancers, and invasive cancers detected.
The results showed that 278,908 women underwent digital mammography images alone and 173,414 women underwent digital mammography plus tomosynthesis. The researchers found that when tomosynthesis was added to digital mammography, there were significant reductions in recall rates for all age groups and significant increases in cancer detection rates for women 40 to 69 years old. The largest recall rate reduction with tomosynthesis was for women who were 40 to 49 years old, decreasing from 137 to 115, for a difference of −22. There was also a simultaneous increase in invasive cancer detection rate with the addition of tomosynthesis in the 40 to 49 age group, from 1.6 to 2.7.
The researchers concluded that by adding tomosynthesis to digital mammography, there was an increase in invasive cancer detection rates for women age 40 to 69 and a decrease in recall rates for all age groups, with largest performance gains seen also in women aged 40 to 49.
“The similar performance seen with tomosynthesis screening for women in their 40s compared to digital mammography for women in their 50s argues strongly for commencement of mammography screening at age 40 using tomosynthesis,” they wrote.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.